Innovation Theaters
These are not official programs of the American College of Rheumatology.
Events
Learn how UCB is committed to patients with BIMZELX® (bimekizumab-bkzx)!
Innovation Theater A
Developed and offered by UCB Commercial
A Bold Step Forward: BE BOLD — A Head-to-Head Superiority Trial in PsA
Innovation Theater A
Developed and offered by UCB, Inc.
Systemic Sclerosis: Connecting Clinical Insights, Biology, and Future Research
Innovation Theater B
Developed and offered by AstraZeneca.
Managing Active PsA Across Multiple Key Domains: A Clinical Discussion on Axial Involvement
Innovation Theater A
Developed and offered by Johnson & Johnson.
Make Rheum for Lungs: Treating Progressive Pulmonary Fibrosis in Your Patients
Innovation Theater A
Developed and offered by Boehringer Ingelheim Pharmaceuticals, Inc.
Identifying Treatment Opportunities for Patients With Lupus Nephritis
Innovation Theater B
Developed and offered by Genentech
Beyond Disease Control: Exploring the Potential of Immune Reset In Autoimmune Disease Through CAR T Clinical Trials
Innovation Theater B
Developed and offered by Genentech.
UPLIZNA: The First and Only FDA-Approved Treatment for IgG4-RD
Innovation Theater A
Developed and offered by Amgen.
Changing Course: Clinical Evidence From the First Head-to-Head Trial Powered to Evaluate the Superiority of Switching to a JAKi Versus Another TNFi After a Single TNF Failure
Innovation Theater B
Developed and offered by AbbVie.
Clinical Insights in Lupus and LN: Revisiting Long-Standing Perceptions with Emerging Evidence
Innovation Theater A
Developed and offered by GSK.
Efficacy, Safety, and Dosing of an Oral Treatment Option for Active Psoriatic Arthritis
Innovation Theater B
Developed and offered by Bristol Myers Squibb
Vagus-Mediated Neuroimmune Modulation for Rheumatoid Arthritis
Innovation Theater A
Developed and offered by SetPoint Medical.
Shared Immunopathology in PMR, GCA, and RA: The Central Role of IL-6
Innovation Theater B
Developed and offered by Sanofi.
What the First FDA-Approved Treatment for Fibromyalgia in Over 15 Years Means for Your Adult Patients
Innovation Theater A
Developed and offered by Tonix Pharmaceuticals.
Bridging the Age Gap: Recognizing MAS Before it is too Late
Innovation Theater B
Developed and offered by Sobi.
Immunoglobulin Therapy: Immune Modulation and Infection Prevention
Innovation Theater A
Developed and offered by Octapharma
Designed for Autoimmunity: Rese-Cel and the RESET Clinical Program
Innovation Theater B
Developed and offered by Cabaletta Bio.


